2022年1-2月阿拉斯加育空-库斯科奎姆三角洲地区COVID-19隔离后抗原检测阳性情况
2022年1月1日至2月9日,育空-库斯科奎姆健康公司(YKHC)报告3502例SARS-CoV-2感染,其中729人在5-9天后接受抗原检测,54.3%(396/729)阳性,阳性率随时间下降。多变量模型显示,5天时抗原阳性可能性高于9天(aOR=6.39),有症状感染高于无症状(aOR=9.63),既往感染(aOR=0.30)、接种基础免疫系列(aOR=0.60)及两者兼有(aOR=0.17)者阳性可能性较低。抗原检测或可辅助指导隔离建议。
要点
- 5-9天后抗原检测阳性率为54.3%(396/729),阳性率随时间下降。
- 5天时抗原阳性可能性高于9天(aOR=6.39),有症状感染高于无症状(aOR=9.63)。
- 既往感染(aOR=0.30)、基础免疫接种(aOR=0.60)及两者兼有(aOR=0.17)者抗原阳性可能性较低。
核心结论
- 抗原检测或可成为指导SARS-CoV-2感染后隔离建议的有用工具。
- 感染后10天内,人们可能对他人具有传染性,建议在他人周围佩戴贴合良好的口罩,即使5天后结束隔离。
研究设计与样本
- 分析2022年1月1日至2月9日报告至YKHC的3502例感染中的抗原检测结果及相关个体特征。
主要发现
- 5-9天后,729名受评估者中396人(54.3%)抗原检测阳性,阳性百分比随时间下降。
- 多变量模型中,5天时抗原检测阳性的可能性高于9天(aOR=6.39)。
- 有症状感染后抗原检测阳性的可能性高于无症状感染(aOR=9.63)。
- 既往感染后抗原检测阳性的可能性较低(aOR=0.30)。
- 接种基础COVID-19疫苗系列后抗原检测阳性的可能性较低(aOR=0.60)。
关键数值与推荐
- 2022年1月5日,YKHC建议SARS-CoV-2感染者自症状出现后隔离10天(无症状者自核酸扩增或抗原检测阳性后隔离10天)。
- 若症状缓解或缺失、无发热≥24小时(未用退热药)且Abbott BinaxNOW COVID-19 Ag快速抗原检测阴性,隔离可在5-9天后结束。
- 感染后10天内,建议在他人周围佩戴贴合良好的口罩,即使5天后结束隔离。
临床怎么用
- 抗原检测或可辅助指导SARS-CoV-2感染后隔离建议。
- 感染后10天内,人们可能对他人具有传染性,建议在他人周围佩戴贴合良好的口罩,即使5天后结束隔离。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Isolation is recommended during acute infection with SARS-CoV-2, the virus that causes COVID-19, but the duration of infectiousness varies among individual persons. Rapid antigen test results have been correlated with detection of viable virus (1-3) and might inform isolation guidance, but data are limited for the recently emerged SARS-CoV-2 B.1.1.529 (Omicron) variant. On January 5, 2022, the Yukon-Kuskokwim Health Corporation (YKHC) recommended that persons with SARS-CoV-2 infection isolate for 10 days after symptom onset (or, for asymptomatic persons, 10 days after a positive nucleic acid amplification or antigen test result). However, isolation could end after 5-9 days if symptoms were resolving or absent, fever was absent for ≥24 hours without fever-reducing medications, and an Abbott BinaxNOW COVID-19 Ag (BinaxNOW) rapid antigen test result was negative. Antigen test results and associated individual characteristics were analyzed among 3,502 infections reported to YKHC during January 1-February 9, 2022. After 5-9 days, 396 of 729 persons evaluated (54.3%) had a positive antigen test result, with a declining percentage positive over time. In a multivariable model, a positive antigen test result was more likely after 5 days compared with 9 days (adjusted odds ratio [aOR] = 6.39) or after symptomatic infection (aOR = 9.63), and less likely after previous infection (aOR = 0.30), receipt of a primary COVID-19 vaccination series (aOR = 0.60), or after both previous infection and receipt of a primary COVID-19 vaccination series (aOR = 0.17). Antigen tests might be a useful tool to guide recommendations for isolation after SARS-CoV-2 infection. During the 10 days after infection, persons might be infectious to others and are recommended to wear a well-fitting mask when around others, even if ending isolation after 5 days.
引用
- Lefferts B, Blake I, Bruden D, et al. Antigen Test Positivity After COVID-19 Isolation - Yukon-Kuskokwim Delta Region, Alaska, January-February 2022. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35202352. doi:10.15585/mmwr.mm7108a3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。